## Core Concept
The question tests understanding of antiretroviral drug resistance and cross-resistance patterns in HIV treatment. Specifically, it focuses on the mechanism of action and resistance profiles of nucleoside reverse transcriptase inhibitors (NRTIs).

## Why the Correct Answer is Right
Abacavir is a nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment of HIV/AIDS. Resistance to Abacavir can arise through specific mutations in the HIV reverse transcriptase gene. The correct answer, , is related to the fact that mutations conferring resistance to certain NRTIs can lead to cross-resistance to Abacavir. Specifically, the K65R mutation, which can be selected by some NRTIs, also confers resistance to Abacavir.

## Why Each Wrong Option is Incorrect
* **Option A:** - This option is incorrect because while is an NRTI, the specific pattern of resistance and cross-resistance does not align closely with Abacavir.
* **Option B:** - This option is incorrect because, although can select for resistance mutations, its resistance profile does not typically show cross-resistance to Abacavir in a clinically significant way.
* **Option D:** - This option is incorrect because is a non-nucleoside reverse transcriptase inhibitor (NNRTI), and its resistance profile is distinct from that of NRTIs like Abacavir. NNRTIs and NRTIs have different mechanisms of action and resistance patterns.

## Clinical Pearl / High-Yield Fact
A key point to remember is that the K65R mutation, which can be selected by certain NRTIs, leads to resistance to Abacavir. This highlights the importance of understanding the resistance profiles of antiretroviral drugs to manage HIV treatment effectively.

## Correct Answer Line
**Correct Answer: C. **